Transmembrane Protein 30B (TMEM30B), also known as CDC50B, is encoded by TMEM30B gene. This gene product is named as cell cycle control protein 50B or P4-ATPase flippase complex beta subunit TMEM30B. TMEM30B gene is located at chromosome 14 and highly conserved in Rhesus monkey, chimpanzee, mouse, cow, zebrafish, rat, and frog. TMEM30B is widely expressed in pancreatic islet, kidney, and prostate, as well as in lung carcinoid, parathyroid tumor, bladder tumor, meningioma, and pancreatic cancer. TMEM30B also has 2 transmembrane domains and an extracellular loop with 3 cysteines and an N-glycosylation site.
|Basic Information of TMEM30B|
|Protein Name||Cell cycle control protein 50B|
|Aliases||P4-ATPase flippase complex beta subunit TMEM30B, CDC50B, Transmembrane protein 30B|
|Organism||Homo sapiens (Human)|
The most well-known role of TMEM30B is to function as an accessory component of P4-ATPase flippase complex, which is a subfamily of P-type ATPases that flip phospholipids across membranes to generate lipid asymmetry, a property vital to many cellular processes. Mutations in several P4-ATPases have been linked to severe neurodegenerative and metabolic disorders. In addition, TMEM30B contributes to the maintenance of the asymmetric distribution of phospholipids and the uptake of lipid signaling molecules and vesicle formation. Moreover, TMEM30B can regulate the export of α subunits ATP8B1, ATP8A1, ATP8B2, and ATP8B4 from the endoplasmic reticulum to the plasma membrane. Other functions of TMEM30B are still unknown clearly. Diseases associated with TMEM30B include Meningioma and Familial.
Fig.1 A structure model of TMEM30B in ModBase. (Ursula, 2014)
This article reveals that ATP8A2 in HEK293T cells assembles with CDC50A, but not CDC50B, to generate a heteromeric complex that actively transports phosphatidylserine and phosphatidylethanolamine across membranes.
This article identifies and characterizes CDC50A, CDC50B(TMEM30B), CDC50C genes of human and mouse in silico.
This article indicates that CDC50 proteins are critical factors in the transport of ATP8B1 to the plasma membrane and thus may be necessary genetic determinants of ATP8B1-related disease.
In order to provide high-quality membrane protein preparation service, we have developed a versatile Magic™ membrane protein production platform. Our experienced scientists will do their best to help you find a perfect match in your required formats. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-TMEM30B antibody development services.
Creative Biolabs is dedicated to providing first-class membrane protein production service using a variety of strategies. Based on our leading-edge platform, we have successfully produced, purified, stabilized and characterized many challenging membrane protein targets for global customers. If you are interested in the service we can provide, please feel free to contact us for more information.